Jaguar Health, Inc. (JAGX) News

Yahoo Finance 15d ago

Two Biotechs Get Beaten Down: Jaguar Health Collapses 59%, Viking Therapeutics Sinks 4%

General T2JAGXVKTX

Investing.com 16d ago

FDA grants fee waivers to Jaguar Health for two drugs

General T3JAGX

Investing.com 1mo ago

Jaguar Health plans MVID drug application for mid-2027

General T3JAGX

Seeking Alpha 1mo ago

Jaguar Health targets mid-2027 MVID NDA filing with possible end-2027 U.S. approval, backed by up to 48% parenteral support reductions

General T2JAGX

Seeking Alpha News 1mo ago

Jaguar Health, Inc. (JAGX) Q2 2026 Earnings Call Prepared Remarks Transcript

Earnings T2JAGX

Seeking Alpha 1mo ago

Jaguar Health GAAP EPS of -$15.68, revenue of $1.23M

Earnings T2JAGX

Seeking Alpha 3mo ago

Jaguar Health reviews strategic alternatives ahead of Crofelemer NDA filing

General T2JAGX

Investing.com 4mo ago

Jaguar Health regains Nasdaq compliance with bid price rule

Markets T3JAGX

Seeking Alpha News 4mo ago

Jaguar Health, Inc. (JAGX) Q1 2026 Earnings Call Prepared Remarks Transcript

Earnings T2JAGX

Motley Fool 4mo ago

Jaguar Health (JAGX) Q3 2025 Earnings Transcript

Image source: The Motley Fool. Nov. 17, 2025, 9 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

Earnings T3JAGX

Seeking Alpha 4mo ago

Jaguar Health GAAP EPS of -$13.60, revenue of $20.27M

Earnings T2JAGX

Motley Fool 4mo ago

Jaguar (JAGX) Q4 2025 Earnings Transcript

Image source: The Motley Fool. Friday, April 10, 2026 at 7 a.m. ET Jaguar Health (NASDAQ:JAGX) delivered a sequential revenue uptick following the out-license of Mytesi and Canalevia-CA1, which generated immediate non-dilutive cash inflows and shifted the company’s revenue mix.…

Earnings T3JAGX